These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 15265637)

  • 21. [Receptor antagonist of NMDA and animal models of schizophrenia].
    Bian SZ; Zhang J; Liu WL; Sun ZH; Gu ZL; Jiang XG
    Fa Yi Xue Za Zhi; 2009 Dec; 25(6):443-6. PubMed ID: 20225623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
    Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
    J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MK-801, a noncompetitive NMDA receptor antagonist, elicits circling behavior in the genetically inbred Balb/c mouse strain.
    Burket JA; Cannon WR; Jacome LF; Deutsch SI
    Brain Res Bull; 2010 Nov; 83(6):337-9. PubMed ID: 20813169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
    Kem WR; Mahnir VM; Papke RL; Lingle CJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide).
    Dunlop J; Lock T; Jow B; Sitzia F; Grauer S; Jow F; Kramer A; Bowlby MR; Randall A; Kowal D; Gilbert A; Comery TA; Larocque J; Soloveva V; Brown J; Roncarati R
    J Pharmacol Exp Ther; 2009 Mar; 328(3):766-76. PubMed ID: 19050173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.
    Cannon CE; Puri V; Vivian JA; Egbertson MS; Eddins D; Uslaner JM
    Neuropharmacology; 2013 Jan; 64():191-6. PubMed ID: 22659472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition.
    Nilsson M; Carlsson A; Markinhuhta KR; Sonesson C; Pettersson F; Gullme M; Carlsson ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):677-85. PubMed ID: 15276693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.
    Enomoto T; Noda Y; Nabeshima T
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):291-301. PubMed ID: 17609743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.
    Manahan-Vaughan D; von Haebler D; Winter C; Juckel G; Heinemann U
    Hippocampus; 2008; 18(2):125-34. PubMed ID: 17924525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of MK-801-induced behavior as a putative rat model of psychosis.
    Andiné P; Widermark N; Axelsson R; Nyberg G; Olofsson U; Mårtensson E; Sandberg M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1393-408. PubMed ID: 10454519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: An animal model of schizophrenia.
    Kesby JP; Burne TH; McGrath JJ; Eyles DW
    Biol Psychiatry; 2006 Sep; 60(6):591-6. PubMed ID: 16697353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nicotinic agonist RJR-2403 compensates the impairment of eyeblink conditioning produced by the noncompetitive NMDA-receptor antagonist MK-801.
    Rodríguez-Moreno A; Carrión M; Delgado-García JM
    Neurosci Lett; 2006 Jul; 402(1-2):102-7. PubMed ID: 16644113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.
    Pietraszek M; Gravius A; Schäfer D; Weil T; Trifanova D; Danysz W
    Neuropharmacology; 2005 Jul; 49(1):73-85. PubMed ID: 15992582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABAergic systems modulate nicotinic receptor-mediated seizures in mice.
    Dobelis P; Hutton S; Lu Y; Collins AC
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1159-66. PubMed ID: 12829730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia.
    Rung JP; Carlsson A; Rydén Markinhuhta K; Carlsson ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):827-32. PubMed ID: 15916843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MK-801 inhibition of nicotinic acetylcholine receptor channels.
    Amador M; Dani JA
    Synapse; 1991 Mar; 7(3):207-15. PubMed ID: 1715611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
    Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
    Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.